Table 3

Prevalence of MetS and its components in patients with SLE

SLE cohort (n=116)
MetS, n (%)34 (29)
Blood pressure
 Arterial hypertension, n (%)68 (59)
 Systolic, median (Q1, Q3)120.5 (113, 134)
 Diastolic, median (Q1, Q3)72 (64, 79)
Obesity
 BMI >30, n (%)19 (16)
 BMI, median (Q1, Q3)23.5 (21.3, 27.8)
Hypertriglyceridaemia
 n (%)37 (32)
 Fasting triglyceride, median (Q1, Q3)0.8 (0.6, 1.0)
Low HDL
 n (%)59 (51)
 Fasting HDL, median (Q1, Q3)1.4 (1.1, 1.8)
Hyperglycaemic
 n (%)26 (22)
 Fasting glucose, median (Q1, Q3)4.7 (4.4, 5.2)
  • Data are n (%) or median (Q1, Q3).

  • BMI, body mass index; HDL, high-density lipoprotein; MetS, metabolic syndrome.